Severe fever with thrombocytopenia syndrome virus (SFTSV) is a tick-borne pathogen that causes fatal hemorrhagic disease in humans and animals. In addition to transmission via tick bites, infection can occur through contact with body fluids from infected individuals or animals. This study evaluated the POCKIT™ Central Nucleic Acid Analyzer (POCKIT Central), a fully automated system integrating nucleic acid extraction and insulated isothermal PCR as a rapid diagnostic tool to aid in preventing the spread of SFTSV infection in veterinary medicine. Analytical sensitivity was assessed using four viral strains; all were detectable, although some exhibited reduced sensitivity. In feline whole blood or serum spiked with SFTSV, the system demonstrated sufficient sensitivity for primary diagnosis of cats showing clinical signs of SFTS. Results of analyses of clinical serum samples using POCKIT Central perfectly matched those obtained using conventional reverse transcription–polymerase chain reaction. The POCKIT Central system can detect SFTSV directly in whole blood or serum within 85 min, without requiring complex manual procedures, thus enabling rapid diagnosis and timely therapeutic intervention in veterinary settings, and it also has the potential for application to other animal species.
{"title":"Fully automated sample-to-answer PCR detection of severe fever with thrombocytopenia syndrome virus in cat serum and whole blood","authors":"Shun Sasaki , Keita Ishijima , Ken Maeda , Marifu Yamagishi-Kondoh","doi":"10.1016/j.jviromet.2026.115353","DOIUrl":"10.1016/j.jviromet.2026.115353","url":null,"abstract":"<div><div>Severe fever with thrombocytopenia syndrome virus (SFTSV) is a tick-borne pathogen that causes fatal hemorrhagic disease in humans and animals. In addition to transmission via tick bites, infection can occur through contact with body fluids from infected individuals or animals. This study evaluated the POCKIT™ Central Nucleic Acid Analyzer (POCKIT Central), a fully automated system integrating nucleic acid extraction and insulated isothermal PCR as a rapid diagnostic tool to aid in preventing the spread of SFTSV infection in veterinary medicine. Analytical sensitivity was assessed using four viral strains; all were detectable, although some exhibited reduced sensitivity. In feline whole blood or serum spiked with SFTSV, the system demonstrated sufficient sensitivity for primary diagnosis of cats showing clinical signs of SFTS. Results of analyses of clinical serum samples using POCKIT Central perfectly matched those obtained using conventional reverse transcription–polymerase chain reaction. The POCKIT Central system can detect SFTSV directly in whole blood or serum within 85 min, without requiring complex manual procedures, thus enabling rapid diagnosis and timely therapeutic intervention in veterinary settings, and it also has the potential for application to other animal species.</div></div>","PeriodicalId":17663,"journal":{"name":"Journal of virological methods","volume":"342 ","pages":"Article 115353"},"PeriodicalIF":1.6,"publicationDate":"2026-01-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146052723","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-01-22DOI: 10.1016/j.jviromet.2026.115352
Hellin Pierre , Everaert Ellen , Demonty Elisabeth , Richet Pauline , Muhovski Yordan , De Jonghe Kris , Hautier Louis , Steyer Stéphan
Beet western yellows virus (BWYV – Polerovirus BWYV) is a polerovirus associated with yellowing and stunting symptoms in sugar beet and several other crops. Its close relationship with other beet-infecting poleroviruses, has long complicated accurate diagnosis due to serological cross-reactivity and limited molecular data. To overcome these issues, we developed a novel real-time RT-PCR assay enabling the specific and sensitive detection of BWYV and beet leaf yellowing virus (BLYV – Polerovirus BLYV). The assay was designed from a curated genomic dataset to ensure inclusivity and tested in parallel with validated reference methods, including a semi-generic ELISA and a generic polerovirus RT-PCR. Comprehensive validation following the EPPO PM 7/98(5) standard confirmed the method’s high analytical sensitivity, specificity, repeatability, and reproducibility. The assay proved robust to methodological variations and compatible with multiplex diagnostic workflows. Compared with existing approaches, it offers faster, more reliable detection and eliminates cross-reactivity with non-target poleroviruses. This method provides a valuable tool for accurate BWYV surveillance and supports improved management of beet virus yellows in agricultural and phytosanitary contexts.
{"title":"Comparative analysis of beet western yellows virus detection methods: Development and validation of a novel real-time RT-PCR assay also targeting beet leaf yellowing virus","authors":"Hellin Pierre , Everaert Ellen , Demonty Elisabeth , Richet Pauline , Muhovski Yordan , De Jonghe Kris , Hautier Louis , Steyer Stéphan","doi":"10.1016/j.jviromet.2026.115352","DOIUrl":"10.1016/j.jviromet.2026.115352","url":null,"abstract":"<div><div>Beet western yellows virus (BWYV – <em>Polerovirus BWYV</em>) is a polerovirus associated with yellowing and stunting symptoms in sugar beet and several other crops. Its close relationship with other beet-infecting poleroviruses, has long complicated accurate diagnosis due to serological cross-reactivity and limited molecular data. To overcome these issues, we developed a novel real-time RT-PCR assay enabling the specific and sensitive detection of BWYV and beet leaf yellowing virus (BLYV – <em>Polerovirus BLYV</em>). The assay was designed from a curated genomic dataset to ensure inclusivity and tested in parallel with validated reference methods, including a semi-generic ELISA and a generic polerovirus RT-PCR. Comprehensive validation following the EPPO PM 7/98(5) standard confirmed the method’s high analytical sensitivity, specificity, repeatability, and reproducibility. The assay proved robust to methodological variations and compatible with multiplex diagnostic workflows. Compared with existing approaches, it offers faster, more reliable detection and eliminates cross-reactivity with non-target poleroviruses. This method provides a valuable tool for accurate BWYV surveillance and supports improved management of beet virus yellows in agricultural and phytosanitary contexts.</div></div>","PeriodicalId":17663,"journal":{"name":"Journal of virological methods","volume":"342 ","pages":"Article 115352"},"PeriodicalIF":1.6,"publicationDate":"2026-01-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146044263","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
The majority of the antibody response in dengue infection targets the structural envelope (E) and membrane (M) proteins of the virus. However, vaccine development is challenging because antibodies against the E protein often show cross-reactivity, leading to antibody-dependent enhancement (ADE) and worsening of disease severity. Non-structural protein 1 (NS1), secreted during the acute phase of infection, has been implicated as a pathogenic factor that contributes to vascular permeability and haemorrhage in severe dengue. In this study, we aimed to investigate the role of NS1 antibodies in disease manifestation. Full-length NS1, along with its N-terminal (NS1A) and C-terminal (NS1B) regions, was expressed and purified to delineate the antibody response against different domains. Serum samples from 102 dengue-positive paediatric patients were analysed for antibody titres against these NS1 constructs using ELISA. Overall higher antibody titres against all three NS1 recombinant proteins were observed in mild cases compared to severe ones with most significant towards NS1A.These findings suggest that antibodies directed against NS1, particularly its N-terminal region, may have a protective role and could serve as a potential correlate of protection in dengue infection.
{"title":"Development of an ELISA using recombinant Dengue NS1 constructs to measure antibody titers and predict dengue disease outcome in a pediatric population in India","authors":"Bharti Pathak , Aparna Chakravarty , N.Veena Rani , Anuja Krishnan","doi":"10.1016/j.jviromet.2026.115351","DOIUrl":"10.1016/j.jviromet.2026.115351","url":null,"abstract":"<div><div>The majority of the antibody response in dengue infection targets the structural envelope (E) and membrane (M) proteins of the virus. However, vaccine development is challenging because antibodies against the E protein often show cross-reactivity, leading to antibody-dependent enhancement (ADE) and worsening of disease severity. Non-structural protein 1 (NS1), secreted during the acute phase of infection, has been implicated as a pathogenic factor that contributes to vascular permeability and haemorrhage in severe dengue. In this study, we aimed to investigate the role of NS1 antibodies in disease manifestation. Full-length NS1, along with its N-terminal (NS1A) and C-terminal (NS1B) regions, was expressed and purified to delineate the antibody response against different domains. Serum samples from 102 dengue-positive paediatric patients were analysed for antibody titres against these NS1 constructs using ELISA. Overall higher antibody titres against all three NS1 recombinant proteins were observed in mild cases compared to severe ones with most significant towards NS1A.These findings suggest that antibodies directed against NS1, particularly its N-terminal region, may have a protective role and could serve as a potential correlate of protection in dengue infection.</div></div>","PeriodicalId":17663,"journal":{"name":"Journal of virological methods","volume":"342 ","pages":"Article 115351"},"PeriodicalIF":1.6,"publicationDate":"2026-01-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146003247","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-01-16DOI: 10.1016/j.jviromet.2026.115350
Muhammad Nadir Shabbir , Thuy Linh Duong
Dengue virus (DENV) infection affects over 390 million people annually, and its severe forms, including dengue hemorrhagic fever (DHF) and dengue shock syndrome (DSS), occur as a result of antibody-dependent enhancement (ADE), T-cell dysregulation, and a cytokine storm. This review integrates the results of human immunopathology with those reported by animal models, consolidating the findings in a systematic manner to validate these mechanisms. Research on AG129 interferon receptor-deficient mice consistently demonstrates ADE-mediated viremia and vascular leakage. However, humanized NSG-BLT mice recapitulate the classic antigenic sin of human T cells after heterotypic challenge with DENV. Cynomolgus macaque models are physiologically relevant for testing tetravalent vaccines under near-human circulatory conditions, and diet-induced obese mice are used to phenotype the effects of metabolic comorbidities on IL-1β-driven immunopathology. Data using standardized methods, including Evans blue extravasation assays, multiplex cytokine panels, and endpoints compliant with the ARRIVE 2.0 guidelines for animal research reporting, were associated with human clinical results. ARRIVE 2.0 is a set of guidelines to improve the transparency and reproducibility of animal research. It is worth noting that early experimental studies on the effectiveness and safety of Dengvaxia reported breakthrough viremia in macaque models. The protection provided by the monoclonal antibody C10 was shown to mitigate antibody-dependent enhancement (ADE) in murine models, though it is not associated with the Dengvaxia vaccine. The further development of these animal models will be necessary to expedite the safe development of next-generation dengue vaccines (TAK-003, TV003/TV005), antivirals (favipiravir, sofosbuvir), and immune modulators (IL-6 and TNF-α blockers) for use in endemic areas.
{"title":"Animal models illuminate dengue immunopathogenesis to guide vaccine and therapeutic developments","authors":"Muhammad Nadir Shabbir , Thuy Linh Duong","doi":"10.1016/j.jviromet.2026.115350","DOIUrl":"10.1016/j.jviromet.2026.115350","url":null,"abstract":"<div><div>Dengue virus (DENV) infection affects over 390 million people annually, and its severe forms, including dengue hemorrhagic fever (DHF) and dengue shock syndrome (DSS), occur as a result of antibody-dependent enhancement (ADE), T-cell dysregulation, and a cytokine storm. This review integrates the results of human immunopathology with those reported by animal models, consolidating the findings in a systematic manner to validate these mechanisms. Research on AG129 interferon receptor-deficient mice consistently demonstrates ADE-mediated viremia and vascular leakage. However, humanized NSG-BLT mice recapitulate the classic antigenic sin of human T cells after heterotypic challenge with DENV. Cynomolgus macaque models are physiologically relevant for testing tetravalent vaccines under near-human circulatory conditions, and diet-induced obese mice are used to phenotype the effects of metabolic comorbidities on IL-1β-driven immunopathology. Data using standardized methods, including Evans blue extravasation assays, multiplex cytokine panels, and endpoints compliant with the ARRIVE 2.0 guidelines for animal research reporting, were associated with human clinical results. ARRIVE 2.0 is a set of guidelines to improve the transparency and reproducibility of animal research. It is worth noting that early experimental studies on the effectiveness and safety of Dengvaxia reported breakthrough viremia in macaque models. The protection provided by the monoclonal antibody C10 was shown to mitigate antibody-dependent enhancement (ADE) in murine models, though it is not associated with the Dengvaxia vaccine. The further development of these animal models will be necessary to expedite the safe development of next-generation dengue vaccines (TAK-003, TV003/TV005), antivirals (favipiravir, sofosbuvir), and immune modulators (IL-6 and TNF-α blockers) for use in endemic areas.</div></div>","PeriodicalId":17663,"journal":{"name":"Journal of virological methods","volume":"342 ","pages":"Article 115350"},"PeriodicalIF":1.6,"publicationDate":"2026-01-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145980345","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-01-12DOI: 10.1016/j.jviromet.2026.115349
Zhifeng Zhang , Yingjun Zhang , Zengqiang Shang , Xiaoli Wang , Yankui Li , Zhaoyu Wang , Longbo Zhao , Ziyan Peng
Fungal viruses compromise the cultivation of Morchella. We surveyed five mycoviruses (Morchella importuna endornavirus 1 [MiEV1], Morchella importuna endornavirus 2 [MiEV2], Morchella importuna endornavirus 3 [MiEV3], Morchella esculenta fusarivirus 1 [MeFV1], and Morchella esculenta fusarivirus 2 [MeFV2]) in 24 cultivated strains (8 M. importuna, 5 M. septimelata, and 11 M. sextelata) collected across 11 provinces in China and evaluated candidate antiviral agents. Only MiEV1 was detected, with a high incidence of 79.2 % (19/24) across all three Morchella species. Among seven tested chemicals (ampicillin, azithromycin, kanamycin, rifampicin, roxithromycin, acyclovir hydrochloride, and ribavirin), only ribavirin significantly inhibited MiEV1 replication. Successive ribavirin treatments eliminated MiEV1 from a representative M. sextelata strain (M11), with the virus-free status remaining stable after multiple subcultures on drug-free medium. Elimination of MiEV1 also significantly enhanced mycelial growth rate and biomass, and led to enhanced mycelial pigmentation, suggesting a potential negative impact of MiEV1 on vegetative growth and pigmentation in M. sextelata. These findings demonstrate that MiEV1 is prevalent in cultivated Morchella and that ribavirin provides an effective strategy for generating stable virus-free strains, offering opportunities for mechanistic studies and industrial cultivation.
{"title":"Prevalence and ribavirin-mediated elimination of Morchella importuna endornavirus 1 (MiEV1) in cultivated Morchella species in China","authors":"Zhifeng Zhang , Yingjun Zhang , Zengqiang Shang , Xiaoli Wang , Yankui Li , Zhaoyu Wang , Longbo Zhao , Ziyan Peng","doi":"10.1016/j.jviromet.2026.115349","DOIUrl":"10.1016/j.jviromet.2026.115349","url":null,"abstract":"<div><div>Fungal viruses compromise the cultivation of <em>Morchella</em>. We surveyed five mycoviruses (Morchella importuna endornavirus 1 [MiEV1], Morchella importuna endornavirus 2 [MiEV2], Morchella importuna endornavirus 3 [MiEV3], Morchella esculenta fusarivirus 1 [MeFV1], and Morchella esculenta fusarivirus 2 [MeFV2]) in 24 cultivated strains (8 <em>M. importuna</em>, 5 <em>M. septimelata</em>, and 11 <em>M. sextelata</em>) collected across 11 provinces in China and evaluated candidate antiviral agents. Only MiEV1 was detected, with a high incidence of 79.2 % (19/24) across all three <em>Morchella</em> species. Among seven tested chemicals (ampicillin, azithromycin, kanamycin, rifampicin, roxithromycin, acyclovir hydrochloride, and ribavirin), only ribavirin significantly inhibited MiEV1 replication. Successive ribavirin treatments eliminated MiEV1 from a representative <em>M. sextelata</em> strain (M11), with the virus-free status remaining stable after multiple subcultures on drug-free medium. Elimination of MiEV1 also significantly enhanced mycelial growth rate and biomass, and led to enhanced mycelial pigmentation, suggesting a potential negative impact of MiEV1 on vegetative growth and pigmentation in <em>M. sextelata</em>. These findings demonstrate that MiEV1 is prevalent in cultivated <em>Morchella</em> and that ribavirin provides an effective strategy for generating stable virus-free strains, offering opportunities for mechanistic studies and industrial cultivation.</div></div>","PeriodicalId":17663,"journal":{"name":"Journal of virological methods","volume":"342 ","pages":"Article 115349"},"PeriodicalIF":1.6,"publicationDate":"2026-01-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145980344","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-01-06DOI: 10.1016/j.jviromet.2026.115337
Khair Rafiq, Sanaullah Khan, Muhammad Bar Khan, Muhammad Yaqoob, Muhammad Adnan
Background
Hepatitis C virus (HCV) infection is a significant health concern that leads to liver complications. The interferon gamma (INF-γ) and interferon gamma receptor-1 (IFN-γR1) genes play role in viral infections. This study aims to analyse the genetic influences of IFN-γ and IFN-γR1 genes polymorphisms on HCV infection outcomes.
Methodology
This cross-sectional study comprised 320 subjects, were classified in to two groups; 160 HCV patients and 160 healthy controls. The HCV patients included 50 subjects with spontaneous viral clearance (SVC), 80 patients with chronic hepatitis C (CHC) and 30 subjects with sustained virological responder (SVR). RNA and DNA were extracted from blood samples. HCV detection and genotyping was performed through PCR. The intron-1 of INF-γ and promoter of IFN-γR1 genes were amplified through PCR and sequenced through Sanger’s method.
Results
The frequency of TT, AT and AA genotypes of IFN-γ at + 874 in HCV positive patients was 62(38.75 %), 64(40 %) and 34(21.5 %); in healthy individuals 73(46.0 %), 61(38.12 %) and 26(16.0 %) (p = 0.153). Genotype AT was significantly high in CHC patients 45(57.0 %) while the TT was considerably high in SVC 27(54.0 %) (p < 0.0001). The frequency of TT, TC, and CC genotypes of IFN-γR1 at −56 was 41(25.64 %), 56(35.0 %), and 63(39.36 %) in HCV patients, while 61(38.13 %), 33(20.63 %) and 66(41.25) in healthy controls (p = 0.0001). The TC genotype was detected high in CHC 34(42.60 %) while the CC was observed more in SVC 24(48.0 %) (P < 0.0001).
Conclusion
IFN-γ AT and IFN-γR1 TC genotypes are associated with Hepatitis C susceptibility, while IFN-γ TT and IFN-γR1 CC may influence recovery.
{"title":"Genetic influence of IFN-γ gene polymorphisms on hepatitis C progression and recovery","authors":"Khair Rafiq, Sanaullah Khan, Muhammad Bar Khan, Muhammad Yaqoob, Muhammad Adnan","doi":"10.1016/j.jviromet.2026.115337","DOIUrl":"10.1016/j.jviromet.2026.115337","url":null,"abstract":"<div><h3>Background</h3><div>Hepatitis C virus (HCV) infection is a significant health concern that leads to liver complications. The interferon gamma (INF-γ) and interferon gamma receptor-1 (IFN-γR1) genes play role in viral infections. This study aims to analyse the genetic influences of IFN-γ and IFN-γR1 genes polymorphisms on HCV infection outcomes.</div></div><div><h3>Methodology</h3><div>This cross-sectional study comprised 320 subjects, were classified in to two groups; 160 HCV patients and 160 healthy controls. The HCV patients included 50 subjects with spontaneous viral clearance (SVC), 80 patients with chronic hepatitis C (CHC) and 30 subjects with sustained virological responder (SVR). RNA and DNA were extracted from blood samples. HCV detection and genotyping was performed through PCR. The intron-1 of INF-γ and promoter of IFN-γR1 genes were amplified through PCR and sequenced through Sanger’s method.</div></div><div><h3>Results</h3><div>The frequency of TT, AT and AA genotypes of IFN-γ at + 874 in HCV positive patients was 62(38.75 %), 64(40 %) and 34(21.5 %); in healthy individuals 73(46.0 %), 61(38.12 %) and 26(16.0 %) (p = 0.153). Genotype AT was significantly high in CHC patients 45(57.0 %) while the TT was considerably high in SVC 27(54.0 %) (p < 0.0001). The frequency of TT, TC, and CC genotypes of IFN-γR1 at −56 was 41(25.64 %), 56(35.0 %), and 63(39.36 %) in HCV patients, while 61(38.13 %), 33(20.63 %) and 66(41.25) in healthy controls (p = 0.0001). The TC genotype was detected high in CHC 34(42.60 %) while the CC was observed more in SVC 24(48.0 %) (P < 0.0001).</div></div><div><h3>Conclusion</h3><div>IFN-γ AT and IFN-γR1 TC genotypes are associated with Hepatitis C susceptibility, while IFN-γ TT and IFN-γR1 CC may influence recovery.</div></div>","PeriodicalId":17663,"journal":{"name":"Journal of virological methods","volume":"342 ","pages":"Article 115337"},"PeriodicalIF":1.6,"publicationDate":"2026-01-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145903961","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-01-05DOI: 10.1016/j.jviromet.2026.115338
Jinfeng Wang , Ruiwen Li , Libing Liu , Jieshi Yu , Ning Li , Xincheng Ji , Yue Yang , Xiaoxia Sun , Wanzhe Yuan , Jianchang Wang
Since the influenza D virus (IDV) was first isolated from a swine exhibiting respiratory disease symptoms in the United States in 2011, it has been detected in various animals across more than 20 countries worldwide, including cattle, pigs, goats, sheep, and camels. IDV has emerged as a significant pathogen associated with bovine respiratory disease complex (BRDC). In this study, specific primers and a TaqMan probe were designed based on the conserved region in the PB1 gene to develop a highly specific and efficient real-time RT-PCR assay (RT-qPCR) for IDV. The RT-qPCR assay demonstrated excellent specificity for IDV, without cross-reactions with other common BRDC-associated pathogens. Using in vitro transcribed PB1 RNA as a template, the assay's limit of detection was established at 100 copies/reaction. Furthermore, the developed RT-qPCR assay was evaluated using 417 cattle nasal swab samples collected from 10 different regions in Hebei Province, China, between 2021 and 2022. The results showed that 33 samples (7.91 %) tested positive for IDV. The IDV HEF gene was amplified and sequenced in these 33 positive samples, yielding 10 HEF gene sequences that all belonged to the D/Yama2019 lineage, with nucleotide homology ranging from 98.7 % to 99.1 %. This study successfully developed an RT-qPCR assay for the specific and sensitive detection of IDV, which performed well on the cattle nasal samples. Additionally, it is the first to demonstrate the presence of IDV in cattle herds in Hebei Province, China.
{"title":"Development and application of a real-time RT-PCR assay for the specific detection of influenza D virus","authors":"Jinfeng Wang , Ruiwen Li , Libing Liu , Jieshi Yu , Ning Li , Xincheng Ji , Yue Yang , Xiaoxia Sun , Wanzhe Yuan , Jianchang Wang","doi":"10.1016/j.jviromet.2026.115338","DOIUrl":"10.1016/j.jviromet.2026.115338","url":null,"abstract":"<div><div>Since the influenza D virus (IDV) was first isolated from a swine exhibiting respiratory disease symptoms in the United States in 2011, it has been detected in various animals across more than 20 countries worldwide, including cattle, pigs, goats, sheep, and camels. IDV has emerged as a significant pathogen associated with bovine respiratory disease complex (BRDC). In this study, specific primers and a TaqMan probe were designed based on the conserved region in the PB1 gene to develop a highly specific and efficient real-time RT-PCR assay (RT-qPCR) for IDV. The RT-qPCR assay demonstrated excellent specificity for IDV, without cross-reactions with other common BRDC-associated pathogens. Using <em>in vitro</em> transcribed PB1 RNA as a template, the assay's limit of detection was established at 100 copies/reaction. Furthermore, the developed RT-qPCR assay was evaluated using 417 cattle nasal swab samples collected from 10 different regions in Hebei Province, China, between 2021 and 2022. The results showed that 33 samples (7.91 %) tested positive for IDV. The IDV HEF gene was amplified and sequenced in these 33 positive samples, yielding 10 HEF gene sequences that all belonged to the D/Yama2019 lineage, with nucleotide homology ranging from 98.7 % to 99.1 %. This study successfully developed an RT-qPCR assay for the specific and sensitive detection of IDV, which performed well on the cattle nasal samples. Additionally, it is the first to demonstrate the presence of IDV in cattle herds in Hebei Province, China.</div></div>","PeriodicalId":17663,"journal":{"name":"Journal of virological methods","volume":"342 ","pages":"Article 115338"},"PeriodicalIF":1.6,"publicationDate":"2026-01-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145917847","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-12-24DOI: 10.1016/j.jviromet.2025.115336
Ranja Steinhauer , Eric Kübler , Stefan Gaugler , Cornel Fraefel , Julia Lechmann
Dried blood spots (DBS) constitute a stable, cost-efficient sampling matrix that can be collected in a minimally invasive manner. Although widely adopted in human medicine, their use in veterinary diagnostics remains limited. This study aimed to establish and validate DBS elution protocols for use in commercial ELISAs to detect antibodies against Hepatitis E virus (HEV), African swine fever virus (ASFV) and Aujeszky’s disease virus (ADV) in domestic pigs. DBS were prepared from EDTA blood, dried serum spots (DSS) from serum. Additional DBS samples were prepared after spiking blood from healthy pigs with antibodies. Various parameters were evaluated to establish the final elution protocols, i.e. number of disks, type and volume of elution buffer, incubation time of the disks in elution buffer, and volume of eluate used for detection. Once the final protocols were in place, for each pathogen 52 DBS were tested in three independent runs. The diagnostic performance was evaluated by comparing the ELISA results of DBS eluates with the corresponding serum or plasma samples. For HEV, only one out of 52 DBS samples qualitatively did not match the plasma result in any of the three runs. For ASFV, all 52 DBS samples matched the qualitative results of the corresponding liquid samples. For ADV, two samples yielded false negative results in all three runs. The results suggest that DBS represent a practical and reliable alternative to liquid blood samples for antibody detection in pigs. Further validation with field samples and large-scale testing is needed.
{"title":"Evaluation of dried blood spot testing for serological monitoring of epizootic and zoonotic pathogens in domestic pigs","authors":"Ranja Steinhauer , Eric Kübler , Stefan Gaugler , Cornel Fraefel , Julia Lechmann","doi":"10.1016/j.jviromet.2025.115336","DOIUrl":"10.1016/j.jviromet.2025.115336","url":null,"abstract":"<div><div>Dried blood spots (DBS) constitute a stable, cost-efficient sampling matrix that can be collected in a minimally invasive manner. Although widely adopted in human medicine, their use in veterinary diagnostics remains limited. This study aimed to establish and validate DBS elution protocols for use in commercial ELISAs to detect antibodies against Hepatitis E virus (HEV), African swine fever virus (ASFV) and Aujeszky’s disease virus (ADV) in domestic pigs. DBS were prepared from EDTA blood, dried serum spots (DSS) from serum. Additional DBS samples were prepared after spiking blood from healthy pigs with antibodies. Various parameters were evaluated to establish the final elution protocols, i.e. number of disks, type and volume of elution buffer, incubation time of the disks in elution buffer, and volume of eluate used for detection. Once the final protocols were in place, for each pathogen 52 DBS were tested in three independent runs. The diagnostic performance was evaluated by comparing the ELISA results of DBS eluates with the corresponding serum or plasma samples. For HEV, only one out of 52 DBS samples qualitatively did not match the plasma result in any of the three runs. For ASFV, all 52 DBS samples matched the qualitative results of the corresponding liquid samples. For ADV, two samples yielded false negative results in all three runs. The results suggest that DBS represent a practical and reliable alternative to liquid blood samples for antibody detection in pigs. Further validation with field samples and large-scale testing is needed.</div></div>","PeriodicalId":17663,"journal":{"name":"Journal of virological methods","volume":"341 ","pages":"Article 115336"},"PeriodicalIF":1.6,"publicationDate":"2025-12-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145834245","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}